Yuya Asanomi, Tetsuaki Kimura, Nobuyoshi Shimoda, Daichi Shigemizu, Shumpei Niida, Kouichi Ozaki. CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer's disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion. Journal of human genetics. 2024
Daichi Shigemizu, Koya Fukunaga, Akiko Yamakawa, Mutsumi Suganuma, Kosuke Fujita, Tetsuaki Kimura, Ken Watanabe, Taisei Mushiroda, Takashi Sakurai, Shumpei Niida, et al. The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer's disease in APOE [Formula: see text]4-negative Japanese adults. npj aging. 2024. 10. 1. 3-3
Daichi Shigemizu, Shintaro Akiyama, Mutsumi Suganuma, Motoki Furutani, Akiko Yamakawa, Yukiko Nakano, Kouichi Ozaki, Shumpei Niida. Classification and deep-learning-based prediction of Alzheimer disease subtypes by using genomic data. Translational psychiatry. 2023. 13. 1. 232-232
Daichi Shigemizu, Shintaro Akiyama, Mutsumi Suganuma, Motoki Furutani, Akiko Yamakawa, Yukiko Nakano, Kouichi Ozaki, Shumpei Niida. Classification and deep-learning-based prediction of Alzheimer disease subtypes by using genomic data. Translational Psychiatry. 2023. 13. 1
Motoki Furutani, Mutsumi Suganuma, Shintaro Akiyama, Risa Mitsumori, Marie Takemura, Yasumoto Matsui, Shosuke Satake, Yukiko Nakano, Shumpei Niida, Kouichi Ozaki, et al. RNA-sequencing analysis identification of potential biomarkers for diagnosis of sarcopenia. The journals of gerontology. Series A, Biological sciences and medical sciences. 2023
